Category: cancer
-
Award-winning band, Arkells, lend impactful song “Strong” to Alberta Cancer Foundation’s latest campaign
•
Article content EDMONTON, Alberta, Dec. 30, 2024 (GLOBE NEWSWIRE) — The Alberta Cancer Foundation has teamed up with 9X JUNO Award-winning band the Arkells to spread a message of hope to Albertans facing cancer. Arkles song is touching, strong– Written for a friend navigating his cancer journey – and serves…
-
My wife, 50, has terminal cancer. Our estate is worth $18 million. How do we prepare?
•
Thank you for all your financial advice. I’m not going to ask you if or when I can afford to retire. I know we are financially fortunate and I know it is embarrassing to give advice to wealthy people. What level of estate planning does one need at different levels…
-
What to eat during cancer treatment
•
Alice Mwakini, 52, a breast cancer fighter, has been battling the disease for two years. As she was diagnosed in October 2022, she faced uncertainty about what she should eat during her treatment. Like many patients, she sought advice from her doctor. The response surprised her. “Just eat anything you…
-
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
•
This section is Partnership content provided The content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire Breadcrumb links Globe Newswire Article writer: Published on October 1, 2024 • 5 minute…
-
RYBREVANT ® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
•
New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT ® plus LAZCLUZE™ regimen compared to osimertinib monotherapy as first-line therapy Results from an interim analysis featured in late-breaker oral presentation at WCLC SAN DIEGO, Sept. 8, 2024 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced…
-
Biden targets tumors with $150 million funding for ‘Cancer Moonshot’ program By Reuters
•
By Andrea Shalal and Garrett Renshaw NEW ORLEANS (Reuters) – U.S. President Joe Biden on Tuesday announced he would allocate $150 million in new federal funding to develop technology to better help surgeons successfully remove cancerous tumors. The award, which Biden promoted during a visit to New Orleans, is the…
-
Biden targets tumors with $150 million funding for ‘Cancer Moonshot’ program By Reuters
•
By Andrea Shalal and Garrett Renshaw NEW ORLEANS (Reuters) – U.S. President Joe Biden on Tuesday announced he would allocate $150 million in new federal funding to develop technology to better help surgeons successfully remove cancerous tumors. The award, which Biden promoted during a visit to New Orleans, is the…
-
Drugmakers’ appeal to end Zantac cancer lawsuits rebuffed by judge By Reuters
•
By Brendan Pearson (Reuters) – A Delaware judge has rejected a request by GlaxoSmithKline and other drugmakers to appeal a ruling that allows more than 70,000 lawsuits alleging that heartburn drug Zantac causes cancer. The ruling by Judge Vivian Medinella of the Delaware Supreme Court means that drug companies, which…
-
Drugmakers’ appeal to end Zantac cancer lawsuits rebuffed by judge By Reuters
•
By Brendan Pearson (Reuters) – A Delaware judge has rejected a request by GlaxoSmithKline and other drugmakers to appeal a ruling that allows more than 70,000 lawsuits alleging that heartburn drug Zantac causes cancer. The ruling by Judge Vivian Medinella of the Delaware Supreme Court means that drug companies, which…
-
Cancer victims lose bid to block proposed J&J talc bankruptcy By Reuters
•
Written by Brendan Pearson (Reuters) – A federal judge on Friday rejected a group of cancer victims’ bid to block Johnson & Johnson from pursuing a proposed bankruptcy settlement of tens of thousands of lawsuits alleging that the company’s baby powder and other talc products contain cancer-causing asbestos. On June…
-
Appeals court does not block US mandate to cover cancer screenings, HIV drugs By Reuters
•
Written by Brendan Pearson (Reuters) – A U.S. appeals court on Friday declined to block a federal order requiring health insurers to cover preventive care services such as cancer screenings and HIV prevention drugs at no additional cost to patients, but ruled against the government in a major legal case…
-
Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate
•
JHVEPhoto/iStock Editorial via Getty Images Merc (New York Stock Exchange: Merck) and its Sichuan partner Kelun-Biotech reported that phase III data on its antibody drug candidate Sacituzumab tirumotecan (sac-TMT) led to a 69% reduction in the risk of progression or death in people with triple-negative breast cancer. From 233 Of…
-
HPV vaccines prevent cancer in men as well as women, but fewer boys are getting the shots, new research suggests
•
New research suggests that the HPV vaccine prevents cancer in men, as well as in women, but fewer boys than girls get vaccinated in the United States. The HPV vaccine was developed to prevent cervical cancer in women, and experts give credit to it, along with screening. Reducing cervical cancer…
-
BioAtla reports promising data in cancer drug trials By Investing.com
•
BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck cancer and is preparing for FDA guidance on…
-
Gritstone bio details progress in cancer vaccine trials By Investing.com
•
Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a positive trend in progression-free survival (PFS) for colorectal cancer patients, with particularly encouraging results in high-risk individuals. The company’s financial position was also…
-
Cancer survivor says embryos created with an ex-husband are her last chance to conceive a child. Ex-husband wants to avoid procreating against his will.
•
A trial is currently underway in Virginia to determine whether state law allows frozen embryos to be considered property that can be divided and assigned a monetary value. Fairfax County Circuit Court Judge Dontae Pugh heard arguments Thursday from a divorced couple who disagreed over their ex-wife’s desire to use…
-
Schrodinger gets rights to cancer drug candidate back from Bristol
•
koto_feja Bristol-Myers Squibb (New York Stock Exchange: BMI) Rights to its preclinical cancer drug candidate, an SOS1 inhibitor, have been returned to Schrödinger (Nasdaq:SDGR). Schrödinger noted that he had submitted a candidate for development, and Bristol was conducting IND-enabled studies on it. The two companies Their collaboration began in 2020,…